Cencora Operating Margin 2010-2023 | COR
Current and historical operating margin for Cencora (COR) over the last 10 years. The current operating profit margin for Cencora as of December 31, 2023 is 0.94%.
| Cencora Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2023-12-31 | $271.58B | $2.53B | 0.93% |
| 2023-09-30 | $262.17B | $2.34B | 0.89% |
| 2023-06-30 | $254.43B | $2.32B | 0.91% |
| 2023-03-31 | $247.54B | $2.14B | 0.86% |
| 2022-12-31 | $241.81B | $2.36B | 0.97% |
| 2022-09-30 | $238.59B | $2.37B | 0.99% |
| 2022-06-30 | $236.33B | $2.47B | 1.05% |
| 2022-03-31 | $229.67B | $2.61B | 1.14% |
| 2021-12-31 | $221.10B | $2.45B | 1.11% |
| 2021-09-30 | $213.99B | $2.35B | 1.10% |
| 2021-06-30 | $204.32B | $-4.32B | -2.11% |
| 2021-03-31 | $196.28B | $-4.54B | -2.31% |
| 2020-12-31 | $194.55B | $-4.85B | -2.49% |
| 2020-09-30 | $189.90B | $-5.14B | -2.70% |
| 2020-06-30 | $186.29B | $1.16B | 0.62% |
| 2020-03-31 | $186.16B | $1.16B | 0.62% |
| 2019-12-31 | $182.06B | $0.90B | 0.49% |
| 2019-09-30 | $179.59B | $1.11B | 0.62% |
| 2019-06-30 | $177.25B | $1.09B | 0.61% |
| 2019-03-31 | $175.15B | $1.07B | 0.61% |
| 2018-12-31 | $172.87B | $1.50B | 0.87% |
| 2018-09-30 | $167.94B | $1.44B | 0.86% |
| 2018-06-30 | $163.76B | $1.15B | 0.70% |
| 2018-03-31 | $159.33B | $0.94B | 0.59% |
| 2017-12-31 | $155.44B | $1.08B | 0.69% |
| 2017-09-30 | $153.14B | $1.06B | 0.69% |
| 2017-06-30 | $151.58B | $1.42B | 0.94% |
| 2017-03-31 | $149.76B | $1.78B | 1.19% |
| 2016-12-31 | $148.31B | $2.10B | 1.42% |
| 2016-09-30 | $146.85B | $1.53B | 1.04% |
| 2016-06-30 | $144.76B | $1.84B | 1.27% |
| 2016-03-31 | $142.11B | $1.65B | 1.16% |
| 2015-12-31 | $139.08B | $0.33B | 0.24% |
| 2015-09-30 | $135.96B | $0.42B | 0.31% |
| 2015-06-30 | $132.08B | $0.09B | 0.07% |
| 2015-03-31 | $128.20B | $-0.13B | -0.10% |
| 2014-12-31 | $123.98B | $0.53B | 0.43% |
| 2014-09-30 | $119.57B | $0.78B | 0.65% |
| 2014-06-30 | $112.45B | $0.69B | 0.61% |
| 2014-03-31 | $104.01B | $0.71B | 0.68% |
| 2013-12-31 | $96.08B | $0.76B | 0.79% |
| 2013-09-30 | $87.96B | $0.90B | 1.02% |
| 2013-06-30 | $82.23B | $1.11B | 1.34% |
| 2013-03-31 | $79.65B | $1.29B | 1.62% |
| 2012-12-31 | $78.83B | $1.32B | 1.68% |
| 2012-09-30 | $78.08B | $1.30B | 1.67% |
| 2012-06-30 | $78.23B | $1.21B | 1.55% |
| 2012-03-31 | $79.07B | $1.21B | 1.52% |
| 2011-12-31 | $79.12B | $1.19B | 1.51% |
| 2011-09-30 | $78.70B | $1.19B | 1.51% |
| 2011-06-30 | $79.35B | $1.20B | 1.51% |
| 2011-03-31 | $78.79B | $1.16B | 1.47% |
| 2010-12-31 | $78.33B | $1.11B | 1.41% |
| 2010-09-30 | $77.78B | $1.09B | 1.40% |
| 2010-06-30 | $76.96B | $1.08B | 1.40% |
| 2010-03-31 | $75.75B | $1.01B | 1.33% |
| 2009-12-31 | $73.76B | $0.95B | 1.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $47.337B | $262.173B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.212B | 15.32 |
| ICON (ICLR) | Ireland | $24.074B | 23.75 |
| DiDi Global (DIDIY) | China | $22.638B | 0.00 |
| Avantor (AVTR) | United States | $16.482B | 22.71 |
| CochLear (CHEOY) | $13.356B | 0.00 | |
| Viatris (VTRS) | United States | $13.340B | 3.81 |
| Revvity (RVTY) | United States | $12.276B | 21.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.132B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.721B | 21.37 |
| Medpace Holdings (MEDP) | United States | $11.598B | 42.15 |
| Solventum (SOLV) | United States | $11.046B | 0.00 |
| Natera (NTRA) | United States | $10.540B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.851B | 51.19 |
| Bausch + Lomb (BLCO) | Canada | $5.032B | 19.35 |
| Doximity (DOCS) | United States | $4.630B | 34.47 |
| Organon (OGN) | United States | $4.566B | 4.42 |
| Sotera Health (SHC) | United States | $3.085B | 15.14 |
| Progyny (PGNY) | United States | $3.064B | 51.42 |
| Surgery Partners (SGRY) | United States | $2.965B | 27.55 |
| Life Times (LTH) | United States | $2.756B | 30.46 |
| GoodRx Holdings (GDRX) | United States | $2.658B | 134.60 |
| Premier (PINC) | United States | $2.491B | 9.12 |
| Teladoc Health (TDOC) | United States | $2.232B | 0.00 |
| Agilon Health (AGL) | United States | $2.203B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.133B | 6.90 |
| BrightSpring Health Services (BTSG) | United States | $1.762B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.444B | 0.00 | |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| NovoCure (NVCR) | Jersey | $1.297B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.964B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.740B | 7.66 |
| Embecta (EMBC) | United States | $0.596B | 3.94 |
| Auna S.A (AUNA) | Luxembourg | $0.549B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.522B | 0.00 |
| Enhabit (EHAB) | United States | $0.507B | 45.96 |
| MultiPlan (MPLN) | United States | $0.475B | 0.00 |
| Beauty Health (SKIN) | United States | $0.423B | 0.00 |
| CareDx (CDNA) | United States | $0.418B | 0.00 |
| LifeMD (LFMD) | United States | $0.412B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.356B | 57.00 |
| Sera Prognostics (SERA) | United States | $0.317B | 0.00 |
| ModivCare (MODV) | United States | $0.286B | 3.79 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.249B | 0.00 |
| Sharecare (SHCR) | United States | $0.227B | 0.00 |
| Biodesix (BDSX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.119B | 40.00 |
| Oncology Institute (TOI) | United States | $0.091B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.015B | 0.00 | |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |